Traitement anti-angiogénique du cancer du sein métastatique : gestion des effets secondaires

Hassan Izzedine, Anti-angiogéniques, hypertension artérielle et toxicité rénale Bulletin Du Cancer. ,vol. 94, pp. 981- 986 ,(2007) , 10.1684/BDC.2007.0498

Napoleone Ferrara, Hans-Peter Gerber, Jennifer LeCouter, None, The biology of VEGF and its receptors. Nature Medicine. ,vol. 9, pp. 669- 676 ,(2003) , 10.1038/NM0603-669

Walter J. Zawacki, T. Gregory Walker, Emily DeVasher, Elkan F. Halpern, Arthur C. Waltman, Stephan T. Wicky, David P. Ryan, Sanjeeva P. Kalva, Wound Dehiscence or Failure to Heal following Venous Access Port Placement in Patients Receiving Bevacizumab Therapy Journal of Vascular and Interventional Radiology. ,vol. 20, pp. 624- 627 ,(2009) , 10.1016/J.JVIR.2009.01.022

Betsy A. George, Xin J. Zhou, Robert Toto, Nephrotic Syndrome After Bevacizumab: Case Report and Literature Review American Journal of Kidney Diseases. ,vol. 49, pp. e23- e29 ,(2007) , 10.1053/J.AJKD.2006.11.024

Vera Eremina, J Ashley Jefferson, Jolanta Kowalewska, Howard Hochster, Mark Haas, Joseph Weisstuch, Catherine Richardson, Jeffrey B Kopp, M Golam Kabir, Peter H Backx, Hans-Peter Gerber, Napoleone Ferrara, Laura Barisoni, Charles E Alpers, Susan E Quaggin, None, VEGF inhibition and renal thrombotic microangiopathy. The New England Journal of Medicine. ,vol. 358, pp. 1129- 1136 ,(2008) , 10.1056/NEJMOA0707330

Jean-Michel Halimi, Michel Azizi, Guillaume Bobrie, Olivier Bouché, Gilbert Deray, Gaetan des Guetz, Thierry Lecomte, Bernard Levy, Jean-Jacques Mourad, Dominique Nochy, Stéphane Oudard, Philippe Rieu, Dil Sahali, Effets vasculaires et rénaux des médicaments anti-angiogéniques : recommandations françaises pour la pratique (SN, SFHTA, APNET, FFCD) Nephrologie & Therapeutique. ,vol. 4, pp. 602- 615 ,(2008) , 10.1016/J.NEPHRO.2008.10.002

Frank A. Scappaticci, Louis Fehrenbacher, Thomas Cartwright, John D. Hainsworth, William Heim, Jordan Berlin, Fairooz Kabbinavar, William Novotny, Somnath Sarkar, Herbert Hurwitz, Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab Journal of Surgical Oncology. ,vol. 91, pp. 173- 180 ,(2005) , 10.1002/JSO.20301

Maurizio Zangari, Louis M. Fink, Francesca Elice, Fenghuang Zhan, Dorothy M. Adcock, Guido J. Tricot, Thrombotic events in patients with cancer receiving antiangiogenesis agents. Journal of Clinical Oncology. ,vol. 27, pp. 4865- 4873 ,(2009) , 10.1200/JCO.2009.22.3875

Elaine Blowers, Kate Hall, Managing adverse events in the use of bevacizumab and chemotherapy. British journal of nursing. ,vol. 18, pp. 351- 358 ,(2009) , 10.12968/BJON.2009.18.6.40767

Xiaolei Zhu, Shenhong Wu, William L. Dahut, Chirag R. Parikh, Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis American Journal of Kidney Diseases. ,vol. 49, pp. 186- 193 ,(2007) , 10.1053/J.AJKD.2006.11.039